Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6146249rdf:typepubmed:Citationlld:pubmed
pubmed-article:6146249lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:6146249lifeskim:mentionsumls-concept:C0003364lld:lifeskim
pubmed-article:6146249lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:6146249lifeskim:mentionsumls-concept:C0376327lld:lifeskim
pubmed-article:6146249pubmed:dateCreated1984-7-30lld:pubmed
pubmed-article:6146249pubmed:abstractTextThere is a reasonable agreement between defined daily doses (DDDs) and prescribed daily doses (PDDs) of antihypertensive drugs, at least in Norway and Sweden. Sales and prescriptions of antihypertensive drugs in seven European countries (CSSR, Denmark, Finland, Iceland, Northern Ireland, Norway and Sweden) have increased 50 to 200% during the last 10 years. The drug statistics also illustrate marked qualitative and quantitative differences in the utilization of antihypertensive drugs between these seven European countries. Mortality in cardiovascular diseases also differs between these countries, particularly between Northern Ireland and Finland and the other countries. So do sales of alcohol and tobacco. However, none of these factors seem to co-vary with drug utilization.lld:pubmed
pubmed-article:6146249pubmed:languageenglld:pubmed
pubmed-article:6146249pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6146249pubmed:citationSubsetIMlld:pubmed
pubmed-article:6146249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6146249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6146249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6146249pubmed:statusMEDLINElld:pubmed
pubmed-article:6146249pubmed:issn0365-463Xlld:pubmed
pubmed-article:6146249pubmed:authorpubmed-author:BaksaasIIlld:pubmed
pubmed-article:6146249pubmed:issnTypePrintlld:pubmed
pubmed-article:6146249pubmed:volume683lld:pubmed
pubmed-article:6146249pubmed:ownerNLMlld:pubmed
pubmed-article:6146249pubmed:authorsCompleteYlld:pubmed
pubmed-article:6146249pubmed:pagination59-66lld:pubmed
pubmed-article:6146249pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:meshHeadingpubmed-meshheading:6146249-...lld:pubmed
pubmed-article:6146249pubmed:year1984lld:pubmed
pubmed-article:6146249pubmed:articleTitlePatterns in drug utilization--national and international aspects: antihypertensive drugs.lld:pubmed
pubmed-article:6146249pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6146249lld:pubmed